Aakaar Medical Technologies Ltd
Incorporated in June 2013, Aakaar Medical Technologies Limited is an aesthetic medical company that offers a diverse selection of specialized cosmetic products and devices.[1]
- Market Cap ₹ 73.8 Cr.
- Current Price ₹ 52.0
- High / Low ₹ 105 / 46.0
- Stock P/E 12.2
- Book Value ₹ 33.3
- Dividend Yield 0.00 %
- ROCE 26.7 %
- ROE 33.8 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 27.0% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 166 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
| Sep 2025 | |
|---|---|
| 25.32 | |
| 25.55 | |
| Operating Profit | -0.23 |
| OPM % | -0.91% |
| 0.30 | |
| Interest | 1.04 |
| Depreciation | 0.05 |
| Profit before tax | -1.02 |
| Tax % | -23.53% |
| -0.78 | |
| EPS in Rs | -0.55 |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 22.89 | 12.44 | 19.47 | 32.78 | 46.11 | 61.58 | |
| 20.01 | 11.54 | 17.07 | 29.25 | 41.11 | 51.84 | |
| Operating Profit | 2.88 | 0.90 | 2.40 | 3.53 | 5.00 | 9.74 |
| OPM % | 12.58% | 7.23% | 12.33% | 10.77% | 10.84% | 15.82% |
| 0.12 | 0.12 | 0.04 | 0.09 | 0.16 | 0.18 | |
| Interest | 0.46 | 0.23 | 0.21 | 0.43 | 1.14 | 1.71 |
| Depreciation | 0.04 | 0.03 | 0.02 | 0.09 | 0.14 | 0.12 |
| Profit before tax | 2.50 | 0.76 | 2.21 | 3.10 | 3.88 | 8.09 |
| Tax % | 26.80% | 28.95% | 26.24% | 30.65% | 26.29% | 25.22% |
| 1.83 | 0.54 | 1.62 | 2.15 | 2.87 | 6.04 | |
| EPS in Rs | 183.00 | 54.00 | 23.14 | 30.71 | 41.00 | 5.80 |
| Dividend Payout % | -0.00% | -0.00% | 34.57% | 24.42% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 22% |
| 3 Years: | 47% |
| TTM: | 34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 55% |
| TTM: | 110% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 29% |
| Last Year: | 34% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.10 | 0.10 | 0.70 | 0.70 | 0.70 | 10.42 | 14.17 |
| Reserves | 6.75 | 7.30 | 7.33 | 8.96 | 11.84 | 12.78 | 32.97 |
| 5.88 | 3.88 | 3.82 | 5.87 | 15.05 | 22.74 | 17.12 | |
| 3.56 | 3.03 | 6.15 | 7.70 | 6.42 | 8.17 | 6.90 | |
| Total Liabilities | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 71.16 |
| 0.06 | 0.04 | 0.20 | 0.36 | 0.28 | 0.24 | 0.22 | |
| CWIP | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 0.47 | 0.11 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| 15.76 | 14.16 | 17.80 | 22.87 | 33.73 | 53.87 | 70.94 | |
| Total Assets | 16.29 | 14.31 | 18.00 | 23.23 | 34.01 | 54.11 | 71.16 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -0.38 | 4.31 | 0.48 | -2.93 | -8.04 | -5.41 | |
| 0.10 | 0.37 | -0.23 | -0.32 | -0.04 | -0.05 | |
| 0.28 | -2.00 | -0.81 | 1.17 | 8.19 | 10.71 | |
| Net Cash Flow | -0.00 | 2.68 | -0.55 | -2.08 | 0.11 | 5.25 |
| Free Cash Flow | -0.40 | 4.30 | 0.29 | -3.19 | -8.09 | -5.49 |
| CFO/OP | 10% | 503% | 47% | -54% | -136% | -35% |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 117.84 | 135.85 | 104.42 | 113.91 | 128.71 | 165.96 |
| Inventory Days | 234.33 | 366.16 | 281.70 | 273.75 | 247.29 | 202.47 |
| Days Payable | 28.20 | 98.96 | 65.19 | 61.56 | 31.74 | 48.84 |
| Cash Conversion Cycle | 323.97 | 403.05 | 320.92 | 326.10 | 344.26 | 319.59 |
| Working Capital Days | 189.44 | 238.25 | 105.17 | 101.55 | 93.96 | 96.85 |
| ROCE % | 8.25% | 20.93% | 25.79% | 23.28% | 26.66% |
Insights
In beta| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Doctor Reach (Cumulative) Number |
|
|||
| Number of Medical Representatives (MRs) Number |
||||
| Revenue per MR (Productivity) INR Lakhs |
||||
| Total SKU Count Number |
||||
| Device Consumables Sold Units |
||||
| New Customers Added Number |
||||
| Number of Billed Customers Number |
||||
Extracted by Screener AI
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
9 April 2026 - Regulation 74(5) compliance noted as not applicable for quarter ended March 31, 2026.
-
General Updates
8 April 2026 - Annual promoter disclosure dated 08 Apr 2026 confirms no share encumbrance in FY2026.
-
Trading Window
28 March 2026 - Trading window closed 01 Apr–17 May 2026 for declaration of audited financial results FY ending 31 Mar 2026.
-
Arrangements for strategic, technical, manufacturing, or marketing tie up
23 February 2026 - 23 Feb 2026: Xelix Partner Clinic to onboard dermatology clinics pan-India; asset-light revenue-sharing model.
-
Analysts/Institutional Investor Meet/Con. Call Updates
23 February 2026 - Group investor meeting on 26 Feb 2026, 2:00 PM at Go India Advisors, BKC, Mumbai.
Annual reports
Concalls
-
Nov 2025Transcript PPT
Business Profile[1]
Aakaar Medical Technologies operates in the medical aesthetics segment, offering a portfolio of aesthetic products and devices through a B2B model. It caters primarily to dermatologists, plastic surgeons, and aesthetic physicians across India.